Search

everythinglearnresearchcommunity

for

Search:↓

The document explains various skin conditions and their treatments.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Chemical relaxers may cause scarring alopecia in black women.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Minoxidil may help with hair regrowth and disease stabilization in scarring alopecia, but side effects vary, needing more research for consistent safety and effectiveness.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

The authors maintain there is a significant link between vitamin D deficiency and central centrifugal cicatricial alopecia in Black patients, and call for more research on the topic.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Hair loss in black women needs more research, early intervention, and community education.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

Black women with CCCA are more likely to have uterine fibroids.

Wearing a high-quality wig improved a woman's mood and life quality, and the authors suggest insurance should cover the cost of wigs.

More research is needed on CCCA in children, especially Black and Asian adolescents.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

Hair follicle bumps with stem cells might contribute to permanent hair loss by getting disconnected due to scarring.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

A woman's hair loss was correctly diagnosed as Lichen planopilaris after initial misdiagnosis, highlighting the usefulness of trichoscopy in diagnosing hair disorders.